rs224206

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000243.3(MEFV):​c.1530T>C​(p.Asp510Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.57 in 1,613,894 control chromosomes in the GnomAD database, including 266,060 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.60 ( 27683 hom., cov: 32)
Exomes 𝑓: 0.57 ( 238377 hom. )

Consequence

MEFV
NM_000243.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:15

Conservation

PhyloP100: -4.78

Publications

29 publications found
Variant links:
Genes affected
MEFV (HGNC:6998): (MEFV innate immunity regulator, pyrin) This gene encodes a protein, also known as pyrin or marenostrin, that is an important modulator of innate immunity. Mutations in this gene are associated with Mediterranean fever, a hereditary periodic fever syndrome. [provided by RefSeq, Jul 2008]
MEFV Gene-Disease associations (from GenCC):
  • familial Mediterranean fever
    Inheritance: AD, AR, SD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Myriad Women’s Health, ClinGen
  • autosomal recessive familial Mediterranean fever
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • familial Mediterranean fever, autosomal dominant
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.97).
BP6
Variant 16-3247073-A-G is Benign according to our data. Variant chr16-3247073-A-G is described in ClinVar as Benign. ClinVar VariationId is 36503.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-4.78 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.707 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MEFVNM_000243.3 linkc.1530T>C p.Asp510Asp synonymous_variant Exon 5 of 10 ENST00000219596.6 NP_000234.1
MEFVNM_001198536.2 linkc.897T>C p.Asp299Asp synonymous_variant Exon 4 of 9 NP_001185465.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MEFVENST00000219596.6 linkc.1530T>C p.Asp510Asp synonymous_variant Exon 5 of 10 1 NM_000243.3 ENSP00000219596.1

Frequencies

GnomAD3 genomes
AF:
0.599
AC:
90981
AN:
151926
Hom.:
27643
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.685
Gnomad AMI
AF:
0.402
Gnomad AMR
AF:
0.628
Gnomad ASJ
AF:
0.552
Gnomad EAS
AF:
0.644
Gnomad SAS
AF:
0.728
Gnomad FIN
AF:
0.559
Gnomad MID
AF:
0.538
Gnomad NFE
AF:
0.539
Gnomad OTH
AF:
0.580
GnomAD2 exomes
AF:
0.612
AC:
153868
AN:
251414
AF XY:
0.606
show subpopulations
Gnomad AFR exome
AF:
0.683
Gnomad AMR exome
AF:
0.740
Gnomad ASJ exome
AF:
0.546
Gnomad EAS exome
AF:
0.656
Gnomad FIN exome
AF:
0.570
Gnomad NFE exome
AF:
0.541
Gnomad OTH exome
AF:
0.571
GnomAD4 exome
AF:
0.568
AC:
829639
AN:
1461850
Hom.:
238377
Cov.:
73
AF XY:
0.570
AC XY:
414494
AN XY:
727228
show subpopulations
African (AFR)
AF:
0.692
AC:
23162
AN:
33480
American (AMR)
AF:
0.729
AC:
32606
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.551
AC:
14393
AN:
26136
East Asian (EAS)
AF:
0.638
AC:
25339
AN:
39700
South Asian (SAS)
AF:
0.714
AC:
61585
AN:
86258
European-Finnish (FIN)
AF:
0.563
AC:
30052
AN:
53412
Middle Eastern (MID)
AF:
0.561
AC:
3236
AN:
5768
European-Non Finnish (NFE)
AF:
0.544
AC:
604565
AN:
1111978
Other (OTH)
AF:
0.575
AC:
34701
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
24173
48346
72518
96691
120864
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
17264
34528
51792
69056
86320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.599
AC:
91082
AN:
152044
Hom.:
27683
Cov.:
32
AF XY:
0.603
AC XY:
44835
AN XY:
74328
show subpopulations
African (AFR)
AF:
0.685
AC:
28423
AN:
41472
American (AMR)
AF:
0.628
AC:
9599
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.552
AC:
1915
AN:
3468
East Asian (EAS)
AF:
0.644
AC:
3326
AN:
5168
South Asian (SAS)
AF:
0.727
AC:
3511
AN:
4830
European-Finnish (FIN)
AF:
0.559
AC:
5901
AN:
10564
Middle Eastern (MID)
AF:
0.524
AC:
154
AN:
294
European-Non Finnish (NFE)
AF:
0.540
AC:
36661
AN:
67952
Other (OTH)
AF:
0.581
AC:
1225
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
1873
3746
5619
7492
9365
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
766
1532
2298
3064
3830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.555
Hom.:
38867
Bravo
AF:
0.608
Asia WGS
AF:
0.703
AC:
2445
AN:
3478
EpiCase
AF:
0.535
EpiControl
AF:
0.531

ClinVar

Significance: Benign
Submissions summary: Benign:15
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Familial Mediterranean fever Benign:5
Aug 18, 2011
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing;curation

- -

Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jul 01, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not specified Benign:4
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Nov 12, 2023
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 89% of patients studied by a panel of primary immunodeficiencies. Number of patients: 85. Only high quality variants are reported. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 27, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Jul 12, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Autoinflammatory syndrome Benign:1
Dec 12, 2016
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Familial Mediterranean fever, autosomal dominant Benign:1
Jul 01, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.97
CADD
Benign
0.074
DANN
Benign
0.31
PhyloP100
-4.8
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs224206; hg19: chr16-3297073; COSMIC: COSV54819248; API